EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Generalized genetic liability to substance use disorders

Alex P Miller, Ryan Bogdan, Arpana Agrawal, Alexander S Hatoum

Journal of Clinical Investigation · 03.06.2024 · 134 (11)

DOI: 10.1172/jci172881 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Investigation, online erschienen am 03.06.2024. Verfasst von Alex P Miller und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and. Hauptthemen laut MEDLINE: Substance-Related Disorders, Genome-Wide Association Study. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIAAA NIH HHS, NIDA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lifetime and temporal co-occurrence of substance use disorders (SUDs) is common and compared with individual SUDs is characterized by greater severity, additional psychiatric comorbidities, and worse outcomes. Here, we review evidence for the role of generalized genetic liability to various SUDs. Coaggregation of SUDs has familial contributions, with twin studies suggesting a strong contribution of additive genetic influences undergirding use disorders for a variety of substances (including alcohol, nicotine, cannabis, and others). GWAS have documented similarly large genetic correlations between alcohol, cannabis, and opioid use disorders. Extending these findings, recent studies have identified multiple genomic loci that contribute to common risk for these SUDs and problematic tobacco use, implicating dopaminergic regulatory and neuronal development mechanisms in the pathophysiology of generalized SUD genetic liability, with certain signals demonstrating cross-species and translational validity. Overlap with genetic signals for other externalizing behaviors, while substantial, does not explain the entirety of the generalized genetic signal for SUD. Polygenic scores (PGS) derived from the generalized genetic liability to SUDs outperform PGS for individual SUDs in prediction of serious mental health and medical comorbidities. Going forward, it will be important to further elucidate the etiology of generalized SUD genetic liability by incorporating additional SUDs, evaluating clinical presentation across the lifespan, and increasing the granularity of investigation (e.g., specific transdiagnostic criteria) to ultimately improve the nosology, prevention, and treatment of SUDs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Substance-Related DisordersGenome-Wide Association StudyHumansGenetic Predisposition to DiseaseMultifactorial Inheritance

Autor:innen und Institutionen

  • Department of Psychiatry and.
  • Department of Psychological and Brain Sciences, Washington University in St. Louis, St. Louis, Missouri, USA.

Förderung

  • NIA NIH HHS
  • NIAAA NIH HHS
  • NIDA NIH HHS
  • NICHD NIH HHS

Zitieren

APA

Miller, A. P., Bogdan, R., Agrawal, A., & Hatoum, A. S. (2024). Generalized genetic liability to substance use disorders. Journal of Clinical Investigation, 134(11). https://doi.org/10.1172/jci172881

Vancouver

Miller AP, Bogdan R, Agrawal A, Hatoum AS. Generalized genetic liability to substance use disorders. Journal of Clinical Investigation. 2024;134(11). doi:10.1172/jci172881

BibTeX
@article{Miller2024,
  author = {Miller, Alex P and Bogdan, Ryan and Agrawal, Arpana and Hatoum, Alexander S},
  title = {Generalized genetic liability to substance use disorders},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  volume = {134},
  number = {11},
  doi = {10.1172/jci172881}
}
Kostenlos starten →